# A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS

> **NCT06917924** · — · RECRUITING · sponsor: **A.O.U. Città della Salute e della Scienza** · enrollment: 200 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DIAGNOSTIC_TEST:** lumbar puncture

## Key facts

- **NCT ID:** NCT06917924
- **Lead sponsor:** A.O.U. Città della Salute e della Scienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-20
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-11-20
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917924, "A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06917924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*